Key result
Depressive symptoms were independently associated with increased all-cause mortality in stable patients with COPD over 8.5 years of follow-up.
Why the study?
Are depressive symptoms associated with increased all-cause mortality in stable patients with COPD?
Cohort (n=121)
Are depressive symptoms associated with increased all-cause mortality in stable patients with COPD?
Depressive symptoms are an independent predictor of all-cause mortality in stable patients with COPD.
Answers are grounded in this paper and cite their sources.
Supports depression assessment in stable COPD; leaves open whether treatment improves survival.
OBJECTIVE: Prognostic studies of mortality in patients with COPD have mostly focused on physiologic variables, with little attention to depressive symptoms. This stands in sharp contrast to the attention that depressive symptoms have been given in the outcomes of patients with other chronic health conditions. The present study investigated the independent association of depressive symptoms in stable patients with COPD with all-cause mortality. METHODS: The baseline characteristics of 121 COPD patients (78 men and 43 women; mean [+/- SD] age, 61.5 +/- 9.1 years; and mean FEV(1), 36.9 +/- 15.5% predicted) were collected on hospital admission to a pulmonary rehabilitation center. The data included demographic variables, body mass index (BMI), post-bronchodilator therapy FEV(1), and Wpeak (peak workload [Wpeak]). Depressive symptoms were assessed using the Beck depression inventory. The vital status was ascertained using municipal registrations. In 8.5 years of follow-up, 76 deaths occurred (mortality rate, 63%). Survival time ranged from 88 days to 8.5 years (median survival time, 5.3 years). The Cox proportional hazard model was used to quantify the association of the baseline characteristics (ie, age, sex, marital status, smoking behavior, FEV(1), BMI, Wpeak, and depressive symptoms) with mortality. RESULTS: Depressive symptoms (odds ratio [OR], 1.93; 95% confidence interval [CI], 1.12 to 3.33) were associated with mortality in patients with COPD, independent of other factors including male sex (OR, 1.73; 95% CI, 1.03 to 2.92), older age (OR, 1.05; 95% CI, 1.02 to 1.08), and lower Wpeak (OR, 0.98; 95% CI, 0.97 to 0.99). CONCLUSIONS: This study provides evidence that depressive symptoms assessed in stable patients with COPD are associated with their subsequent all-cause mortality.
No takes yet. Share an insight, caveat, or question.
Voogd et al. (2008) conducted a cohort in COPD (n=121). Depressive symptoms vs. No or lower depressive symptoms was evaluated on All-cause mortality (OR 1.93, 95% CI 1.12-3.33). Depressive symptoms were independently associated with increased all-cause mortality in stable patients with COPD over 8.5 years of follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: